Back to mobile site

RBC Capital Downgrades Avalo Therapeutics Inc. (AVTX) to Sector Perform

June 26, 2023 11:41 PM EDT Send to a Friend
(Updated - June 27, 2023 6:24 AM EDT)

RBC Capital analyst Gregory Renza downgraded Avalo Therapeutics Inc. (NASDAQ: AVTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login